Skip to content

Effect of probiotics on the outcome of asymptomatic bacterial vaginosis

Effect of probiotics on the outcome of asymptomatic bacterial vaginosis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019436
Enrollment
Unknown
Registered
2018-11-11
Start date
2018-11-30
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial vaginosis

Interventions

experimental group:lactobacillus live capsule for vaginal use
control group:placebo capsule for vaginal use

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 45 years old, with history of sexual activity, and clinically diagnosed as asymptomatic BV. 2. Criteria for clinical diagnosis of asymptomatic BV: Microecological analysis of vaginal secretions of patients; 3. Nugent score greater than 3 points, and patients without clinical symptoms (leucorrhea, odor, vulvar pruritus).

Exclusion criteria

Exclusion criteria: Nither of the following will not be accepted: 1) those with clinical symptoms; 2) mixed vaginitis. 3) asymptomatic VVC; 4) since the onset of the disease, any drug has been used; 5) At the same time accompanied by any of the following diseases: pelvic inflammation, cervicitis, vaginitis, other gynecological inflammatory diseases (mycoplasma, chlamydia, gonorrhea, syphilis); 6) those with serious organ diseases; 7) during pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
recurrence rate;

Secondary

MeasureTime frame
PD;stable;

Countries

China

Contacts

Public ContactZhang Rui

Peking University First Hospital

zuniverse@163.com+86 15210310516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026